Narrative Review

Recently published articles about Narrative Review

JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
Narrative Review

August 19, 2024

While the pathophysiology of schizophrenia is complex, treatments with novel pharmacological actions that target these systems are of interest as adjunctive treatment for schizophrenia.
Bruce J. Kinon, Stefan Leucht, Carol Tamminga, et al
PCC
Management of ADHD in Adolescents and Young Adults
Narrative Review

August 6, 2024

Drawing on their clinical experiences of implementing evidence-based guidelines and feedback from patients, the authors describe innovative strategies and solutions for improving the management of ADHD in adolescents and...
Tom Janzen, Samuel Chang, Geraldine Farrelly
PCC
Tech Gaming Designs, Neurodevelopmental Vulnerabilities, and Internet Gaming Disorder Risk
Narrative Review

July 23, 2024

The authors review the relevant research in the field of internet gaming disorder and provide an approach to identification and management.
Maneesh Chidambaram, Mayank Gupta, Nihit Gupta
JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
Mina M. Rizk, Lindsay Bolton, Flurin Cathomas, et al
PCC
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
Narrative Review

January 30, 2024

While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.
Leslie Citrome, Christoph U. Correll, Luis San, et al
PCC
Neuropsychiatric Manifestations and Management of Tuberous Sclerosis
Narrative Review

January 4, 2024

Ninety percent of individuals with tuberous sclerosis have associated neuropsychiatric manifestations including ADHD, autism spectrum disorder, and intellectual disability, which are typically underidentified and undertreated.
Parul Gupta, Mamidipalli Sai Spoorthy, Pooja R. Raikar

Recent JCP Articles on Narrative Review

JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to...
Mark A. Frye, Balwinder Singh, Scott A. Breitinger, et al
JCP
Reproductive Pharmacovigilance and Best Practices
Commentary

August 26, 2024

Dr Freeman discusses a recent study by Pacilio et al that characterized real world practices around ketamine treatment and pregnancy testing, consent processes, and contraception use. She emphasizes the...
Marlene P. Freeman
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
Chittaranjan Andrade

Recent PCC Articles on Narrative Review

PCC
Panic Attacks Masquerading as Intractable Vomiting
Case Report

August 22, 2024

The authors present a perplexing and atypical manifestation of panic attacks presenting as intractable vomiting in a young patient.
Ajzal A. Zain, Tanvi Mittal, Nishanth Jalaja Haridas
PCC
Smartphone Applications: Therapy at Your Fingertips
Letter to the Editor

August 20, 2024

The authors discuss the advancements in smartphone applications for psychiatry, as well as some of the risks.
Vania Modesto-Lowe, Sofia Adams, Amanda Rossi
PCC
Zeroing in on Xylazine
Letter to the Editor

August 15, 2024

The authors discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.
Jasleen Kaur, Megan Nosol, Vania Modesto-Lowe

Featured Narrative Review Research

Scientists Find Environmental Plastics in Human Brains
news

August 23, 2024

Research reveals that plastics are accumulating in human brains, with concentrations in the frontal cortex rising by more than 50%.
Weekly Mind Reader: When is Vomiting Not a Gut Problem?
news

August 23, 2024

This week features a report on chronic vomiting, a review of the economic impact of cognitive impairment, and how apps can advance care.
University Develops AI-Powered Brain Implant for Parkinson’s Patients
news

August 22, 2024

Researchers developed an AI-driven brain implant that offers 24-hour treatment for Parkinson's, improving movement and sleep symptoms.
PCC
Fentanyl-Contaminated Oxycodone
Narrative Review

November 9, 2023

The growing use of fentanyl-contaminated products is fueling the US opioid crisis. This study reviewed the rising prevalence of nonprescription fentanyl in counterfeit oxycodone, paying specific attention to oxycodone...
Grace E. Hartmann, Roopa Sethi
PCC
Xylazine as a Fentanyl Adulterant in the US
Narrative Review

October 31, 2023

Data obtained from studies between 2006 and 2022 indicate a rapidly increasing incidence of xylazine overdose in the United States, with overdose cases now being seen in 25 states.
Caitlin E. Leconte, Roopa Sethi
PCC
Eating Disorders and Reproductive Health
Narrative Review

August 31, 2023

Recognition and treatment of eating disorders in women prior to conception can minimize obstetric risks to the woman and potential long-term adverse effects on the offspring.
Suzanne M. Bailey-Straebler, Leah C. Susser
PCC
Wernicke’s Encephalopathy in Patients With Psychiatric History
Narrative Review

July 20, 2023

Wernicke’s encephalopathy can present concomitantly with psychiatric decompensation, often requiring treatment with both neuroleptics and thiamine.
Tanya Peguero Estevez, Carmen E. Casasnovas, Minira Aslanova, et al
PCC
L-Methylfolate as Adjunctive Therapy in MDD Treatment
Narrative Review

May 9, 2023

l-Methylfolate is effective as an adjunctive treatment in MDD and may especially benefit patients with higher body mass index and inflammation.
Vladimir Maletic, Richard Shelton, Valerie Holmes
l-Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder">
PCC
Collaborative Care Model Education Opportunities
Narrative Review

April 25, 2023

The Collaborative Care Model (CoCM) is an evidence-based methodology to improve access to mental health care, but studies on how CoCM is taught are sparse. Future opportunities abound to...
Patrick A. Ho, Eduardo Andres Calagua-Bedoya, Bennis Pavisian, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe